Identification |
Name: | 1,3,8-Triazaspiro[4.5]decan-4-one,8-[(2,3-dihydro-1,4-benzodioxin-2-yl)methyl]-1-phenyl- |
Synonyms: | 1,3,8-Triazaspiro[4.5]decan-4-one,8-(1,4-benzodioxan-2-ylmethyl)-1-phenyl- (7CI,8CI); 1,4-Benzodioxin,1,3,8-triazaspiro[4.5]decan-4-one deriv.;8-(1,4-Benzodioxan-2-ylmethyl)-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one; R5188; Spiroxatrine |
CAS: | 1054-88-2 |
Molecular Formula: | C22H25 N3 O3 |
Molecular Weight: | 379.45 |
InChI: | InChI=1/C22H25N3O3/c26-21-22(25(16-23-21)17-6-2-1-3-7-17)10-12-24(13-11-22)14-18-15-27-19-8-4-5-9-20(19)28-18/h1-9,18H,10-16H2,(H,23,26) |
Molecular Structure: |
|
Properties |
Flash Point: | 318.4°C |
Boiling Point: | 602.8°Cat760mmHg |
Density: | 1.32g/cm3 |
Refractive index: | 1.665 |
Biological Activity: | 5-HT 1A antagonist. More active and selective than spiperone. Also a very potent α 2C adrenergic receptor antagonist. |
Flash Point: | 318.4°C |
Color: | white |
Safety Data |
|
|